Volume: 6 Issue: 1
Year: 2018, Page: 13-16,
Introduction: In South East Asia, India has turn out to be one of the major producers of alcohol. Hepatic manifestation of alcohol includes fatty liver, alcoholic hepatitis and chronic hepatitis with hepatic fibrosis or cirrhosis.
Objective : The main aim of our study was to determine the concentrations of some important physiological metal ions and liver enzyme activity in chronic alcoholics.
Materials and Methods : This was a case control study. The study involved 30 male patients of Alcoholic liver diseases (ALDs) from outpatient and inpatients department of Prathima Institute of Medical Sciences (PIMS) Karimnagar as cases and 30 age-matched healthy male relatives of patients with no chronic illness as control group. AST, ALT, bilirubin, gamma glutamyl transferase (GGT) and serum zinc, magnesium and copper of cases and controls were estimated compared.
Results :In the current study we found that serum bilirubin levels, serum AST, ALT, GGT rose significantly in cases (P<0.001) when compared to controls. The cases have significantly lower level of serum Zinc and Magnesium when compared to healthy normal controls (P<0.0001). There is a significant elevation of serum copper levels in cases when compared to the healthy controls (P<0.001).
Conclusion Except copper both serum zinc and magnesium levels significantly reduced in ALD patients. The liver enzymes elevated in the chronic alcoholics denoting hepatic impairment in the cases. The estimation of the enzymes and cations helps in early diagnosis and also as prognostic marker for treatment in ALD patients.
Keywords: Fibrosis, cirrhosis, gamma glutamyl tranferase, ALD
1. MacSween RN, Burt AD. Histologic spectrum of alcoholic liver disease. Semin Liver Dis 1986;6:221-232.
2. Crabb DW. Pathogenesis of alcoholic liver disease: newer mechanisms of injury. Keio J Med 1999;48:184-188.
3. Lieber CS, Jones DP, Decarli LM. Effects of prolonged ethanol intake: production of fatty liver despite adequate diets. J Clin Invest 1965;44: 1009-1021.
4. Mendenhall CL. Anabolic steroid therapy as an adjunct to diet in alcoholic hepatic steatosis. Am J Dig Dis 1968;13:783-791.
5. Leevy CM. Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature. Medicine (Baltimore) 1962;41:249-276.
6. Sorensen TI, Orholm M, Bentsen KD, Hoybye G, Eghoje K, Christoffersen P. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 1984;2:241-244.
7. Teli MR, Day CP, Burt AD, Bennett MK, James OF. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 1995;346:987-990.
8. Kitte O,Ferry N. Mature hepatocytes activity divide and express gamma-glutamyltranspeptidase after Dgalactosamin liver injury. Liver.1998;18:398-404.
9. Countay L.,Heisterkamp N.,Siest G. Expression of multiple ?-glutamyl transferase genes in man. Biochem.J.1994;297:503-508.
10. Spencer-peet J.,Wood D.,Glatt MM. Screening test for alcoholism. Lancet. 1972; 1: 1122-3.
11. RosalkiSB.,Rau D. serum ?-glutamyltranspeptidase activity in alcoholism. Clin Chem Acta 1972;39:41-7.
12. Dibley M.J. pre in nutrition. Eighteen edKenpaku sha; Tokyo: 2002;pp:344-345.
13. Krebs N.F.overview of zinc absorption and excretion in human gastrointestinal tract. J.Nutr. 2000;130(5S):1374s1377s.
14. Bounous ID.,Wyatt RD.,Gibbs PS,Kilburn JV,Quist CF. Hematologic and serum biochemical reference intervals for juvenile wild turkeys. J.of Wildlife Disease. 2000;36(2):393-396.
15. Dean AG, Sullivan KM, Soe MM. OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version. www.OpenEpi.com, updated 2013/04/06, accessed 2017/ 03/01
17. Gupta S, Pandey R, Katyal R, Aggarwal HK, Aggarwal RP, et al. Aggarwal SK. The lipid peroxide and antioxidant status in alcoholic liver diseases. Indian J Clin Biochem. 2005; 20: 67-71.
18. Das SK, Nayak P, Vasudevan DM. Biochemical markers of alcohol consumption. Ind J Clin Biochem. 2003; 18(2): 111- 118.
19. Reyes E, Miller WR. Serum gamma-glutamyl transpeptidase as a diagnostic aid in problem drinkers. Addict Behav. 1980; 5; 59-65.
20. Rodríguez-Moreno F, González-Reimers E, SantolariaFernández F, Galindo-Martín L, Hernandez-Torres O, Batista-López N et al. Zinc, Copper, Magnesium, and iron in chronic alcoholic liver disease. Alcohol. 1997. Vol 14(1): 39-44
21. Quaye IK, Nyame PK, Dodoo D, Gyan B, Adjei AA. Biochemical and haematological markers of alcohol intake in Ghanaians. West Afr J Med. 1992;11:199–202.
22. Conde-Martel, A.; Gonzfilez-Reimers, E.; SantolariaFernfindez, F.;Castro-Alemgm, V.; Galindo-Martin, L.; 16 Navid, et al Rodrfguez-Moreno, F.: Martfnez-Riera, A. Combined effects of ethanol and protein deficiency on hepatic iron, zinc, manganese, and copper contents. Alcohol 9:341-348; 1992.
23. Singh M, Gupta S, Singhal U, Pandey R, Aggarwal SK. Evaluation of the Oxidative Stress in Chronic Alcoholics. Journal of Clinical and Diagnostic Research?: JCDR. 2013;7(8):1568-1571.
Shah Navid, Srinivas Ch, Bhagyalakshmi K. Serum concentration of selected trace elements and Gamma- glutamyltransferase in alcoholic liver disease. Perspectives in Medical Research 2018;6(1):13-16.